355 related articles for article (PubMed ID: 33268826)
1. Viroimmunotherapy for breast cancer: promises, problems and future directions.
Chaurasiya S; Fong Y
Cancer Gene Ther; 2021 Aug; 28(7-8):757-768. PubMed ID: 33268826
[TBL] [Abstract][Full Text] [Related]
2. The viral approach to breast cancer immunotherapy.
Arab A; Behravan N; Razazn A; Barati N; Mosaffa F; Nicastro J; Slavcev R; Behravan J
J Cell Physiol; 2019 Feb; 234(2):1257-1267. PubMed ID: 30146692
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic Virotherapy for Breast Cancer Treatment.
O Bryan SM; Mathis JM
Curr Gene Ther; 2018; 18(4):192-205. PubMed ID: 30207220
[TBL] [Abstract][Full Text] [Related]
4. Introduction to Oncolytic Virotherapy.
Engeland CE; Bell JC
Methods Mol Biol; 2020; 2058():1-6. PubMed ID: 31486028
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic virotherapy: Challenges and solutions.
Goradel NH; Baker AT; Arashkia A; Ebrahimi N; Ghorghanlu S; Negahdari B
Curr Probl Cancer; 2021 Feb; 45(1):100639. PubMed ID: 32828575
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic virotherapy of breast cancer.
Hartkopf AD; Fehm T; Wallwiener D; Lauer UM
Gynecol Oncol; 2011 Oct; 123(1):164-71. PubMed ID: 21764108
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective.
Ebrahimi S; Ghorbani E; Shafiee M; Ryzhikov M; Hassanian SM; Azadmanesh K
J Cell Biochem; 2019 Mar; 120(3):2801-2809. PubMed ID: 30260014
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances.
Kwan A; Winder N; Muthana M
Viruses; 2021 Jun; 13(6):. PubMed ID: 34208264
[TBL] [Abstract][Full Text] [Related]
9. Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3.
Sagara M; Miyamoto S; Itoh S; Soda Y; Tani K
Anticancer Res; 2021 Jan; 41(1):81-89. PubMed ID: 33419801
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
Cejalvo JM; Falato C; Villanueva L; Tolosa P; González X; Pascal M; Canes J; Gavilá J; Manso L; Pascual T; Prat A; Salvador F
Cancer Treat Rev; 2022 May; 106():102392. PubMed ID: 35436729
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance.
Totsch SK; Schlappi C; Kang KD; Ishizuka AS; Lynn GM; Fox B; Beierle EA; Whitley RJ; Markert JM; Gillespie GY; Bernstock JD; Friedman GK
Oncogene; 2019 Aug; 38(34):6159-6171. PubMed ID: 31289361
[TBL] [Abstract][Full Text] [Related]
13. Crossing the boundaries: stem cells and gene therapy.
Ferguson SD; Ahmed AU; Thaci B; Mercer RW; Lesniak MS
Discov Med; 2010 Mar; 9(46):192-6. PubMed ID: 20350484
[TBL] [Abstract][Full Text] [Related]
14. Employing tumor hypoxia for oncolytic therapy in breast cancer.
Chun YS; Adusumilli PS; Fong Y
J Mammary Gland Biol Neoplasia; 2005 Oct; 10(4):311-8. PubMed ID: 16826462
[TBL] [Abstract][Full Text] [Related]
15. Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies.
Cilibrasi C; Papanastasopoulos P; Samuels M; Giamas G
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769447
[TBL] [Abstract][Full Text] [Related]
16. Developing Oncolytic Viruses for the Treatment of Cervical Cancer.
Kalafati E; Drakopoulou E; Anagnou NP; Pappa KI
Cells; 2023 Jul; 12(14):. PubMed ID: 37508503
[TBL] [Abstract][Full Text] [Related]
17. Anticancer gene transfer for cancer gene therapy.
Pazarentzos E; Mazarakis ND
Adv Exp Med Biol; 2014; 818():255-80. PubMed ID: 25001541
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Viruses: Therapeutics With an Identity Crisis.
Breitbach CJ; Lichty BD; Bell JC
EBioMedicine; 2016 Jul; 9():31-36. PubMed ID: 27407036
[TBL] [Abstract][Full Text] [Related]
19. Current strategies of virotherapy in clinical trials for cancer treatment.
Lin W; Zhao Y; Zhong L
J Med Virol; 2021 Aug; 93(8):4668-4692. PubMed ID: 33738818
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic viruses as a promising therapeutic strategy for hematological malignancies.
Yang C; Hua N; Xie S; Wu Y; Zhu L; Wang S; Tong X
Biomed Pharmacother; 2021 Jul; 139():111573. PubMed ID: 33894623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
